Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

NanoDelivery 2018

About Us

International Conference and Exhibition on Nanomedicine and Drug Delivery May 14-16, 2018 Tokyo, Japan

ConferenceSeries Ltd is a renowned organization that organizes highly notable Pharmaceutical Conferences throughout the globe. Currently we are bringing forth International Conference on Nanomedicine and Drug Delivery” (NanoDelivery 2018) scheduled to be held during May 14-16, 2018 at Tokyo, Japan. The conference invites all the participants across the globe to attend and share their insights and convey recent developments in the field of Nanomedicine and Drug Delivery.

ConferenceSeries Ltd organizes a conference series of 1000+ Global Events inclusive of 1000+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

2018 Highlights:

  • 300+ Participation (70 Industry: 30 Academia)
  • 10+ Keynote Speakers
  • 50+ Plenary Speakers
  • 20+ Exhibitors
  • 14 Innovative Educational Sessions
  • 5+ Workshops
  • B2B Meetings

Nanomedicine and drugdelivery will account for 40% of a $136 billion nanotechnology-enabled drug delivery market by 2021. We forecast the total market size in 2021 to be US$136 billion, with a 60/40 split between nano medicine and drug delivery respectively, although developing new targeted delivery mechanisms may allow more value to be created for companies and entrepreneurs.

However, the Asia-Pacific region is expected to grow at a faster CAGR owing to presence of high unmet healthcare needs, research collaborations and increase in nanomedicine research funding in emerging economies such as Japan, China, India and other economies in the region. Japan is expected to surpass the United States in terms of nanotechnology funding in the near future, which indicates the growth offered by this region.This conference seeks to showcase work in the area of Nanomedicine, Drug Delivery Systems, and nanotechnology, Nanobiothechnology, particularly related to drug delivery.  

For More PS: http://nanomedicine.pharmaceuticalconferences.com/

(Click here for any queries)

Nanomedicine and drugdelivery can address one of the greatest challenges in the post-genomic era of the 21st century – making the essential connections between Academics and industry professionals.

To meet these challenges, the field of Nanomedicine and drugdelivery has undergone exponential growth during the last 5 years. Technologies such as Personalized Nanomedicine,  Design of Nanodrugs, Synthesis of Nanoparticles for Drug Delivery, Regenerative Medicine and Tissue Engineering, Nanomedicines and Biomedicalapplications, Nanomaterials  for drug delivery, Regulatory Aspects Towards Approval of Nanomedicine, NanoPharmaceutical Industry and Market processing and drug delivery promise to transform the world of nanomedicines and drug delivery much in the same way that integrated and transformed the world of pharmaceutical sciences.

Nanodelivery 2018 has everything you need:

Open panel discussions: Providing an open forum with experts from academia and business to discuss on current challenges in nanomedicine and drugdelivery, where all attendees can interact with the panel followed by a Q&A session.

Speaker and poster presentations: Providing a platform to all academicians and industry professionals to share their research thoughts and findings through a speech or a poster presentation.

Editorial board meeting: Discussing on growth and development of open access Nanomedicine and drugdelivery International Journals and recruiting board members and reviewers who can support the journal.

Round table meetings: Providing a platform where industry professionals meet academic experts.

Over 50+ organizations and international pavilions will be exhibiting at the Nanodelivery 2017 conference and Exhibition. Exhibitors will include equipment manufacturers and suppliers, systems providers, finance and investment firms, R&D companies, project developers, trade associations, and government agencies.

In addition to the products and services you will see at the Nanodelivery Exhibition, you will have access to valuable content, including Keynote Presentations, Product Demonstrations and Educational Sessions from today’s industry leaders.

The Nanodelivery 2017 has everything you need, all under one roof, saving you both time and money.   It is the event you cannot afford to miss!

Who's Coming to Nanodelivery 2018?

  • CEOs / CMOs                                                          
  • CTOs  
  • VPS, Directors, & Managers
  • World top Ranked Scientists                           
  • Researchers                                                            
  • Universities
  • Medical Devices
  • Pharmaceuticals companies
  • Tool and Materials companies
  • And Many More....

                       

 

Sessions/Tracks

The field of Nano Delivery now has pivotal roles in electronics, biology and medicine. Its application can be appraised, as it involves the materials to be designed at atomic and molecular level. Due to the advantage of their size, nanospheres have been shown to be robust drug delivery systems and may be useful for encapsulating drugs and enabling more precise targeting with a controlled release. In this review specifically, we highlight the recent advances of this technology for medicine and drug delivery systems.  Nanomaterials range from 10–200 nm up to a few micrometres in size, and include nano- and microparticles, nanotubes and quantum dots.

Nanotechnological devices are made from metals, polymers, lipids and organic substances as well as from macromolecules such as dendrimers, antibodies, micelles, liposomes and nanofibers. Nanomedicine makes use of these nanostructures for diagnostic or therapeutic applications in all fields of medicine, using them for drug delivery, biosensors, neuro-electronic interfaces, in vivo imaging, and cell-specific molecular interactions, where "cell repair machines" could revolutionize medicine and the medical field. As drug delivery systems, nanoparticles can be designed to improve the pharmacological and therapeutic properties of drugs. The strength of nanoparticulate drug delivery systems is their ability to alter the pharmacokinetics and biodistribution of drugs.

ConferenceSeries Ltd organizes a conference series of 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.    

Track 1: Nanomedicine

Nanomedicine seeks to deliver a valuable set of research tools and clinically useful devices. The pharmaceutical industry is developing new commercial applications that may include advanced drug delivery systems, new therapies, and Nanomaterials for Imaging and Drug Delivery. Another active and very much related area of research is the investigation of toxicity and environmental impact of nanoscale materials, since nanomedicines must be biocompatible for clinical application.

Related Conferences:

Nanomaterials Conference, March 30-31, 2017, Madrid, Spain; Medical Nanotechnology Summit May 22-23, 2017, Osaka, International Conference on Pharmaceutics and Drug Delivery, March 13-15, 2017 London, UK; 2nd International Conference on Nanomedicine, Drug Delivery, and Tissue Engineering, April 05-06, 2017, Barcelona, Spain; 19th  International Conference on Nanotechnology and Nanomedicine, July 9 - 10, 2017, Prague, Czech Republic; European Nanomedicine Meeting 2017, April  3-4, 2017, London, UK; 19thInternational Conference on Nanotechnology and Nanomedicine, June 21 - 22, 2017, Vienna, Austria; 4thWorld Congress and Expo on Nanotechnology and Materials Science, April 05-07, 2017, Barcelona, Spain. Nano Canadian SocietyAmerican Nano SocietyAmerican Society for NanomedicineSociety for Personalized NanomedicineRoyal Society-NanoTechnology and NanoScience.

Track 2:    Design of Nanodrugs

To reach target cell, designing of nanodrugs are major aspects, where researcher interested for developing novel Nanodrugs.

Aimed and specially designed session for researchers developing Nanodrugs for delivery of amino acids, Nucleic acids and proteins. The session Design of Nanodrugs includes: Novel Drugs to Nano Drugs, Nanodrugs for Cancer Therapy, Nanodrugs for Veterinary Therapeutics, Nanodrugs for Medical applications and Nanodrugs for Herbal medicines and Cosmetics.

Related conferences:

Nanomaterials Conference, March 30-31, 2017, Madrid, Spain; Medical Nanotechnology Summit May 22-23, 2017, Osaka, International Conference on Pharmaceutics and Drug Delivery, March 13-15, 2017 London, UK; 2nd International Conference on Nanomedicine, Drug Delivery, and Tissue Engineering, April 05-06, 2017, Barcelona, Spain; 19th  International Conference on Nanotechnology and Nanomedicine, July 9 - 10, 2017, Prague, Czech Republic; European Nanomedicine Meeting 2017, April  3-4, 2017, London, UK; 19thInternational Conference on Nanotechnology and Nanomedicine, June 21 - 22, 2017, Vienna, Austria; 4thWorld Congress and Expo on Nanotechnology and Materials Science, April 05-07, 2017, Barcelona, Spain. Nano Canadian SocietyAmerican Nano SocietyAmerican Society for NanomedicineSociety for Personalized NanomedicineRoyal Society-NanoTechnology and NanoScience.

Track 3: Nanomedicine and Nanotechnology

Nanotechnology for cancer is a field that incorporates the studies related to nanosized particles, their function and behavior with respect to different systems. The tremendous capabilities of nanoparticles have changed the perspective and scope of nanotechnology towards development into an adjuvant field for the remaining fields of life sciences. The role of nanotechnology in the field of pharmaceutics has tremendously changed the way of our understanding about drugs, nanodrugs or the use of nanoparticles as carrier of drug has become the basic fundamental or criteria for the production or design of a drug and advances in nanotechnology.

Nanotechnology is an important field of modern research dealing with design, synthesis, and manipulation of particle structures ranging from approximately 1-100 nm.

The session Design of Nanomedicine and Nanotechnology includes broad  topics like:  Carbon Nanotubes, Nanoparticles, Gold Nanoparticles, Silver Nanoparticles, Magnetic Nanoparticles, Nano Micro Particles, Nanocomposite Microspheres, Biosensors and Nanobioelectronics, Bio inspired materials and drug delivery and Nanobiomechanics and Nanomedicine.

Related conferences:

Nanomaterials Conference, March 30-31, 2017, Madrid, Spain; Medical Nanotechnology Summit May 22-23, 2017, Osaka, International Conference on Pharmaceutics and Drug Delivery, March 13-15, 2017 London, UK; 2nd International Conference on Nanomedicine, Drug Delivery, and Tissue Engineering, April 05-06, 2017, Barcelona, Spain; 19th  International Conference on Nanotechnology and Nanomedicine, July 9 - 10, 2017, Prague, Czech Republic; European Nanomedicine Meeting 2017, April  3-4, 2017, London, UK; 19thInternational Conference on Nanotechnology and Nanomedicine, June 21 - 22, 2017, Vienna, Austria; 4thWorld Congress and Expo on Nanotechnology and Materials Science, April 05-07, 2017, Barcelona, Spain. Nano Canadian SocietyAmerican Nano SocietyAmerican Society for NanomedicineSociety for Personalized NanomedicineRoyal Society-NanoTechnology and NanoScience.

Track 4: Synthesis of Nanoparticles for Drug Delivery

Nanoparticles (NPs) have wide range of applications in areas such as health care, cosmetics, food and feed, environmental health, mechanics, optics, biomedical sciences, chemical industries, electronics, space industries, drug-gene delivery, energy science, optoelectronics, catalysis, single electron transistors, light emitters, nonlinear optical devices, and photo-electrochemical applications.

Synthesizing nanoparticles for pharmaceutical purposes such as drug preparation can be done in two methods. Bottom up process such as pyrolysis, inert gas condensation, solvothermal reaction, sol-gel fabrication and structured media in which hydrophobic compound such as liposomes are used as bases to mount the drug. Top down process such as attrition / milling in which the drug is chiseled down to form a nanoparticle

Nanocarriers, Gold Nanoparticles, Silver Nanoparticles, Liposomes, ligands, Nanoemulsions , Solid Lipid Nanoparticles, Polymeric Nanoparticles, Dendrimer Nanocarriers, Silica materials and Carbon Nanocarriers, nanotechnology and medicine.

Related conferences:

Nanomaterials Conference March 30- 31, 2017 Madrid,Spain;  Medical Nanotechnology Summit May 22-23, 2017 Osaka, Japan; Molecular Nanoscience Meeting October 20-22, 2016 Rome, Italy; Nanotechnology Expo November 10-12 2016, Australia; Nanotech  Expo December 5-7 2016, USA; International Conference on Nanoscience and Nanotechnology (ICONN), 7–11 February 2016, Australia;  International Conference on Nanobiotechnology, Drug Delivery, and Tissue Engineering, 1st - 2nd April 2016, Czech Republic;  International Conference on Biotechnology, Bioengineering and Nanoengineering, April 14-15, 2016, Portugal;  Meeting and Expo on Nanomaterials and Nanotechnology, 25th - 27th April 2016, UAE;  NANOTEXNOLOGY , 2–9 July, 2016, Greece. Nano Canadian Society, American Nano Society, American Society for Nanomedicine, Society for Personalized Nanomedicine.

Track 5:  Regenerative Medicine and Tissue Engineering

The promise of regenerative medicine is truly remarkable. Regenerative medicine is a new branch of medicine that attempts to change the course of chronic disease, in many instances regenerating failing organ systems lost due to age, disease, damage, or congenital defects. The area is rapidly becoming one of the most promising treatment options for patients suffering from tissue failure.

Tissue Engineering and Regenerative Medicine is appealing to scientists, physicians, and lay people alike: to heal tissue or organ defects that the current medical practice deems difficult or impossible to cure.

It covers numerous topics, such as stem cells, cell culture, polymer synthesis, novel biomaterials, drug delivery, therapeutics, and the creation of tissues and organs.

This session dedicated to helping provide research-based solutions to issues related to human diseases and include with sessions as: tissue engineering, Organ fabrication, Tissue printing, Biomaterials, Biologic scaffolds, Hydrogels, Cell seeded matrices, Bioreactor design, Mechanical conditioning of engineered tissues, Mechanical properties of engineered tissues, Physiological properties of engineered tissues, Clinical outcomes of engineered tissue implantation, Cell-based therapies.

Related conferences: 

Tissue Engineering and Regenerative Medicine Conference Aug 20-22, 2017 Baltimore, USA;  Stem Cell And Regenerative Medicine Meetings March 20-22, 2017 Berlin, Germany; 8th World Congress on Stem Cell Research March 20-22, 2017 Orlando, USA; 5th International Conference on Cell and Gene  Therapy May 19-21, 2016 San Antonio, USA; International Conference on Restorative Medicine October 24-26, 2016 Chicago, USA; International Conference on Molecular Biology October 13-15, 2016 Dubai, UAE; 2nd International Conference on Tissue preservation and Biobanking  September12-13, 2016 Philadelphia USA; Conference on Cardiac Development, Regeneration and Repair April 3 – 7, 2016 Snowbird, Utah, USA; The Conference on Stem Cell Development ,May 22-26, 2016 Hillerød, Denmark; Conference on  Hematopoietic Stem Cells:  June 3-5, 2016 Heidelberg, Germany; ISSCR Pluripotency Conference March 22-24, 2016 Kyoto, Japan , Royal Society-NanoTechnology and NanoScience, International Association of Nanotechnology (IANT), American Association for the Advancement of Science , Nano Canadian Society, American Nano Society, American Society for Nanomedicine, Society for Personalized Nanomedicine.

 Track 6: Nanomedicine in Theranostics

Theranostic nanomedicine is emerging as a promising therapeutic paradigm. It takes advantage of the high capacity of nanoplatforms to ferry cargo and loads onto them both imaging and therapeutic functions. The resulting nanosystems, capable of diagnosis, drug delivery and monitoring of therapeutic response, are expected to play a significant role in the dawning era of personalized medicine, and much research effort has been devoted toward that goal.

Related Conferences:

Nanomaterials Conference March 30- 31, 2017 Madrid,Spain;  Medical Nanotechnology Summit May 22-23, 2017 Osaka, Japan; Molecular Nanoscience Meeting October 20-22, 2016 Rome, Italy; Nanotechnology Expo November 10-12 2016, Australia; Nanotech  Expo December 5-7 2016, USA; International Conference on Nanoscience and Nanotechnology (ICONN), 7–11 February 2016, Australia;  International Conference on Nanobiotechnology, Drug Delivery, and Tissue Engineering, 1st - 2nd April 2016, Czech Republic;  International Conference on Biotechnology, Bioengineering and Nanoengineering, April 14-15, 2016, Portugal;  Meeting and Expo on Nanomaterials and Nanotechnology, 25th - 27th April 2016, UAE;  NANOTEXNOLOGY , 2–9 July, 2016, Greece. Nano Canadian Society, American Nano Society, American Society for Nanomedicine, Society for Personalized Nanomedicine.

Track 7: Nanomedicines and Biomedical Applications

Nanomedicine seeks to deliver a valuable set of research tools and clinically useful devices. The pharmaceutical industry is developing new commercial applications that may include advanced drug delivery systems, new therapies, and Nanomaterials for Imaging and Drug Delivery. Another active and very much related area of research is the investigation of toxicity and environmental impact of nanoscale materials, since nanomedicines must be biocompatible for clinical application.

Nanomaterials Conference March 30- 31, 2017 Madrid,Spain;  Medical Nanotechnology Summit May 22-23, 2017 Osaka, Japan; Molecular Nanoscience Meeting October 20-22, 2016 Rome, Italy; Nanotechnology Expo November 10-12 2016, Australia; Nanotech  Expo December 5-7 2016, USA; International Conference on Nanoscience and Nanotechnology (ICONN), 7–11 February 2016, Australia;  International Conference on Nanobiotechnology, Drug Delivery, and Tissue Engineering, 1st - 2nd April 2016, Czech Republic;  International Conference on Biotechnology, Bioengineering and Nanoengineering, April 14-15, 2016, Portugal;  Meeting and Expo on Nanomaterials and Nanotechnology, 25th - 27th April 2016, UAE;  NANOTEXNOLOGY , 2–9 July, 2016, Greece. Nano Canadian Society, American Nano Society, American Society for Nanomedicine, Society for Personalized Nanomedicine.

Track 8: Drug Delivery Research

Drug Delivery Conferences attains greater global significance as Drug Delivery plays a significant role in the future of pharmaceutical research Novel drug delivery system method by which a drug is delivered can have a significant effect on its efficacy. Conference includes topics like lipid Polymers to enhance drug delivery technology by providing controlled release of therapeutic agents in constant doses over long periods, cyclic dosage, and tunable release of both hydrophilic and hydrophobic drugs. In vitro & in vivo dissolution testing is required to ensure that drug dissolves at a consistent rate from batch to batch of formulated drug product. Improvement of dissolution rate of poorly soluble drugs can be increased by dissolving them in liquid hydrophilic vehicles followed by soaking on highly porous materials. The major part is to deliver an innovative speech on the latest Targeted drug delivery is a method of delivering medication to a patient in a manner that increases the concentration of the medication in some parts of the body relative to others. Pharmacokinetic behavior in drug design and drug development for safety issues arising either as a result of animal toxicity testing or in the clinical program itself

Related Conferences: 

10th Pharmaceutics and  Novel Drug Delivery Systems Conference, March 13-15, 2017 London, UK; 6th  Annual Conferences on European Pharma Congress, July 10-12, 2017 Madrid, Spain; 3nd International Conference on Biopharmaceutics June 22-23, 2017 Baltimore, USA; 3nd  International Conference on Biologic Drugs, June 22-23, 2017 Baltimore, USA; 6rd World Congress on Pharmacology August 7-9, 2017 Paris, France; 2nd International Conference on Parenterals, December 05-07, 2016 Texas, USA; 2nd International Conference on Injectables  December 05-07, 2016, Texas, USA; Respiratory Drug Delivery Conference, April  25-28, 2017 France; Drug Delivery Partnership,  February 7-9, 2017 Florida USA;  6th International Conference on Drug Formulation, 6th International Conference on Solubility March 20-22, 2017 Philadelphia, USA, 6th  International  Conference on Bioavailability, March 20-22, 2017 Philadelphia, USA; Congress on Innovation in Drug Delivery (APGI), Controlled Release Society (CRS), International Society for Aerosols in Medicine (ISAM),  The Pharmaceutical and Healthcare Sciences Society (PHSS), Nano Canadian Society, American Nano Society, American Society for Nanomedicine, Society for Personalized Nanomedicine.

Track 9: Novel Drug Delivery Systems

To maximize knowledge of the current researcher on developing drug delivery systems via Novel techniques for Pharmaceutical formulation development, Drug Delivery conference themed quality topics on Liposomes, Dendrimer, Targeted Drug Delivery design, versatile polymer in Drug Delivery and Controlled Drug Delivery, Trans mucosal Drug Delivery, Blood Brain Barrier, Optimization of pharmaceutical products, Sustained Drug Delivery Systems, are a uniquely architect session to play an important role in the fields of pharmaceutical formulation development and Pharmacology.

Related Conferences: 

10th Pharmaceutics and  Novel Drug Delivery Systems Conference, March 13-15, 2017 London, UK; 6th  Annual Conferences on European Pharma Congress, July 10-12, 2017 Madrid, Spain; 3nd International Conference on Biopharmaceutics June 22-23, 2017 Baltimore, USA; 3nd  International Conference on Biologic Drugs, June 22-23, 2017 Baltimore, USA; 6rd World Congress on Pharmacology August 7-9, 2017 Paris, France; 2nd International Conference on Parenterals, December 05-07, 2016 Texas, USA; 2nd International Conference on Injectables  December 05-07, 2016, Texas, USA; Respiratory Drug Delivery Conference, April  25-28, 2017 France; Drug Delivery Partnership,  February 7-9, 2017 Florida USA;  6th International Conference on Drug Formulation, 6th International Conference on Solubility March 20-22, 2017 Philadelphia, USA, 6th  International  Conference on Bioavailability, March 20-22, 2017 Philadelphia, USA; Congress on Innovation in Drug Delivery (APGI), Controlled Release Society (CRS), International Society for Aerosols in Medicine (ISAM),  The Pharmaceutical and Healthcare Sciences Society (PHSS), Nano Canadian Society, American Nano Society, American Society for Nanomedicine, Society for Personalized Nanomedicine.

Track 10: Smart Drug Delivery Technology

To maximize knowledge of the current researcher on developing drug delivery via Pharmaceutical formulation,  Smart Drug Delivery conference themed quality topics on Drug Targeting, Drug Designing, Drug evaluation, Drug Delivery and Therapeutics,  Biodegradable polymers, Dendrimer a versatile polymer in drug delivery are a uniquely architect session to play an important role in the fields of nanotechnology, pharmaceutical and medicinal chemistry.

Major drugs driving growth of the overall smart drug delivery market include Angiomax, Copaxone, Forteo, Sandostatin, Velcade, Victoza and Zoladex

Related Conferences:    

10th Pharmaceutics and  Novel Drug Delivery Systems Conference, March 13-15, 2017 London, UK; 6th  Annual Conferences on European Pharma Congress, July 10-12, 2017 Madrid, Spain; 3rd International Conference on Biopharmaceutics June 22-23, 2017 Baltimore, USA; 3rd  International Conference on Biologic Drugs, June 22-23, 2017 Baltimore, USA; 6rd World Congress on Pharmacology August 7-9, 2017 Paris, France; 2nd International Conference on Parenterals, December 05-07, 2016 Texas, USA; 2nd International Conference on Injectables  December 05-07, 2016, Texas, USA; Respiratory Drug Delivery Conference, April  25-28, 2017 France; Drug Delivery Partnership,  February 7-9, 2017 Florida USA;  6th International Conference on Drug Formulation, 6th International Conference on Solubility March 20-22, 2017 Philadelphia, USA, 6th  International  Conference on Bioavailability, March 20-22, 2017 Philadelphia, USA; Congress on Innovation in Drug Delivery (APGI), Controlled Release Society (CRS), International Society for Aerosols in Medicine (ISAM),  The Pharmaceutical and Healthcare Sciences Society (PHSS), Nano Canadian Society, American Nano Society, American Society for Nanomedicine, Society for Personalized Nanomedicine.

Track 11: Nano Pharmaceuticals

Pharmaceutical Nanotechnology for Drug Delivery using Nanotechnology session plays major role in the future of pharmaceutical research. In this session, we will go over several of the most important features of nanotechnology, anticancer drug development , pharmocology of cancer drugs, that will impact our lives but we will also talk about what nanotechnology itself will be like in the future and Investigator specifically from cancer therapy. Interestingly pharmaceutical sciences are using nanoparticles to reduce toxicity and side effects of drugs and up to recently did not realize that carrier systems themselves may impose risks to the patient.

Nano technology session includes drug delivery using nanotechnology, Pharmaceutical technology, Nanoparticles permeability to BBB, Cancer drug targets, Nanoparticles application, Pancreatic Cancer, Nanoliposome-mediated delivery, MicroRNA therapeutics, recent breakthroughs in nanoparticle design to demonstrate their high potential as multifunctional drug delivery nanocarrier, Carriers for nanotechnology, various nanostructures, magnetic nanoparticles. In this review Polymer Nanotechnology for Drug Delivery, Nano composite materials, to deliver highly efficient therapeutic compounds to patient a future aspect of Nanotechnology has a vast future ahead of it and we are constantly making breakthroughs in this industry every day.  

Related Conferences: 

20th International Conference on Nanoscience, Dec 19-20, 2017 Osaka, Japan 11th International Conference on Molecular Nanotechnology, October 20-22, 2016 Rome, Italy, UK; International Conference on Nano medicine, July 24-25, 2017 Melbourne, Australia; Conference on Nanotechnology in Health Care , July 24-25, 2017 Melbourne, Australia; 3rd International Conference on Biopharmaceutics June 22-23, 2017 Baltimore, USA; 3rd  International Conference on Biologic Drugs, June 22-23, 2017 Baltimore, USA; 6rd World Congress on Pharmacology August 7-9, 2017 Paris, France; 2nd International Conference on Parenterals, December 05-07, 2016 Texas, USA; 2nd International Conference on Injectables  December 05-07, 2016, Texas, USA; Respiratory Drug Delivery Conference, April  25-28, 2017 France; Drug Delivery Partnership,  February 7-9, 2017 Florida USA;  6th International Conference on Drug Formulation, 6th International Conference on Solubility March 20-22, 2017 Philadelphia, USA, 6th  International  Conference on Bioavailability, March 20-22, 2017 Philadelphia, USA; Congress on Innovation in Drug Delivery (APGI), Controlled Release Society (CRS), International Society for Aerosols in Medicine (ISAM),  The Pharmaceutical and Healthcare Sciences Society (PHSS), Nano Canadian Society, American Nano Society, American Society for Nanomedicine, Society for Personalized Nanomedicine.

Track 12: Nano Biotechnology

Nanobiotechnology is the intersection of nanotechnology and biology. Nanobiotechnology has multitude of potentials for advancing medical science thereby improving health care practices around the world. Nanomedicine is used to treat diseases by gene therapy. Nano biotechnologies are being applied to molecular diagnostics and several technologies are in development.

Related Conferences:

Nanomaterials Conference March 30- 31, 2017 Madrid,Spain;  Medical Nanotechnology Summit May 22-23, 2017 Osaka, Japan; Molecular Nanoscience Meeting October 20-22, 2016 Rome, Italy; Nanotechnology Expo November 10-12 2016, Australia; Nanotech  Expo December 5-7 2016, USA; International Conference on Nanoscience and Nanotechnology (ICONN), 7–11 February 2016, Australia;  International Conference on Nanobiotechnology, Drug Delivery, and Tissue Engineering, 1st - 2nd April 2016, Czech Republic;  International Conference on Biotechnology, Bioengineering and Nanoengineering, April 14-15, 2016, Portugal;  Meeting and Expo on Nanomaterials and Nanotechnology, 25th - 27th April 2016, UAE;  NANOTEXNOLOGY , 2–9 July, 2016, Greece. Nano Canadian Society, American Nano Society, American Society for Nanomedicine, Society for Personalized Nanomedicine.

Track 13: Nano Pharmaceutical Industry and Market

Nano Pharmaceutical Industry Companies and Market session is beginning to change for small, medium, and large scale pharmaceutical Co, biopharmaceutical Manufacturing and Industries ,  generic drugs companies, contract drug delivery companies which can manifest from development to manufacturing. Addressing these instabilities is a great challenge, because of the complexity of the Clinical bio therapeutics themselves. This session includes Rheological behavior, Pharmaceutical Guidelines, Pharmaceutical companies and regulatory guidelines perspectives, Advances in computational modeling for bioavailability, drug Stability of Pharmaceutical products which are driving crucial research into new vaccines and medicines. The pharmaceutical industry and the public sector are thinking differently than before about how to improve access to medicines and advance research and development for neglected diseases.

Related Conferences:  

International Conference on Pharma Marketing Conference, November 17-19, 2016 Alicante, Spain; 4th  Annual conferences on European Pharma Congress, June 13-15, 2016 Berlin, Germany; 2nd  International Conference on Biologic Drugs, September 15-17, 2016 San Antonio, USA; 3rd World Congress on Pharmacology August 08-10, 2016 Birmingham, UK; 2nd International Conference on Parenterals, December 05-07, 2016 Dallas, Texas, USA; 2nd International Conference on Injectables December 05-07, 2016 Dallas, Texas, USA; Respiratory Drug Delivery Conference, April 25-28, 2017 France; Drug Delivery Partnership,  February 7-9, 2017 Florida USA;  6th International Conference on Drug Formulation, 6th International Conference on Solubility March 20-22, 2017 Philadelphia, USA, 6th  International  Conference on Bioavailability, March 20-22, 2017 Philadelphia, USA; Congress on Innovation in Drug Delivery (APGI), Controlled Release Society (CRS), International Society for Aerosols in Medicine (ISAM),  The Pharmaceutical and Healthcare Sciences Society (PHSS), Nano Canadian Society, American Nano Society, American Society for Nanomedicine, Society for Personalized Nanomedicine.

Track 14: Regulatory Aspects Towards Approval of Nanomedicine

Nanoethics is the study ethical and social implications of nanotechnology’s. It is an emerging but controversial field. Nanoethics is a debatable field. As the research is increasing on nanomedicine, there are certain regulations to increase their efficacy and address the associated safety issues. Other issues in nanoethics include areas like research ethics, environment, global equity, economics, politics, national security, education, life extension and space exploration.

Related Conferences:

Nanomaterials Conference March 30- 31, 2017 Madrid,Spain;  Medical Nanotechnology Summit May 22-23, 2017 Osaka, Japan; Molecular Nanoscience Meeting October 20-22, 2016 Rome, Italy; Nanotechnology Expo November 10-12 2016, Australia; Nanotech  Expo December 5-7 2016, USA; International Conference on Nanoscience and Nanotechnology (ICONN), 7–11 February 2016, Australia;  International Conference on Nanobiotechnology, Drug Delivery, and Tissue Engineering, 1st - 2nd April 2016, Czech Republic;  International Conference on Biotechnology, Bioengineering and Nanoengineering, April 14-15, 2016, Portugal;  Meeting and Expo on Nanomaterials and Nanotechnology, 25th - 27th April 2016, UAE;  NANOTEXNOLOGY , 2–9 July, 2016, Greece. Nano Canadian Society, American Nano Society, American Society for Nanomedicine, Society for Personalized Nanomedicine.

Market Analysis

Summary of Nanodelivery 2018 Conference:

Nano Delivery 2018 is an emerging field of engineering and life sciences that promises to revolutionize medicine and medical technology. There are numerous applications of nanomedicine and nanotechnology in medicinal diagnostics. These include improved imagining of the human (or any) body and detecting tumors that are only a few cells in size.

The idea that pharmaceutical agents should be delivered specifically to diseased cells holds the promise of a variety of benefits. The promise of individualized medicine is that it is efficient. Targeted drug-delivery allows doctors and patients to benefit from small dosages at just the right place and thus from fewer side effects.

Nanomedicine has therapeutic uses as well. Nanotechnology is capable of delivering medication to the exact location where they are needed, hence lesser side effects. It can also be used to destroy harmful organisms or cancer cells by interrupting their division process. Nanoprobes can be made to generate radiation that could kill bacteria, viruses and cancer cells. Nanotechnology also theoretically allows the mimicking of natural biological processes, e.g. repair of damaged tissues or acting as artificial red blood cells to transport oxygen.

The global market for healthcare nanotechnology is expected to reach USD 196.02 billion by 2020 growing at a CAGR of 12.1%, according to a new study by Grand View Research, Inc. Increasing susceptibility of patients towards chronic diseases such as cardiovascular, neurological, oncology and respiratory diseases coupled with increasing R&D spending opening new application avenues is expected to drive market growth over the next six years. Other drivers of this market include increasing government and private sector R&D aid and new players entering the market to bridge the gap between supply and demand.

Importance & Scope of Nano Delivery:

Researchers are developing a nanoparticle that can be taken orally and pass through the lining of the intestines into the bloodsteam. This should allow drugs that must now be delivered with a shot to be taken in pill form. The researchers have demonstrated the technique with lab mice so far.

Researchers are also developing a nanoparticle to defeat viruses. The nanoparticle does not actually destroy viruses molecules, but delivers an enzyme that prevents the reproduction of viruses molecules in the patients bloodstream. The effectiveness of the technique has been demonstrated in lab tests.

Nanomedicine Market in Japan:

Nanomedicine is a promising sub-segment in medicine that took off in the 1980s with the first generation of developed nanopharmaceuticals. With the use of nanotechnology, drugs can be delivered in ways not experienced so far.U.S. is a strong actor in this field with many patents having commercialized several nanopharmaceuticals.

The global nanomedicine market was valued at US$50.1 billion in 2011 and is projected to grow to US$96.9 billion in 2016. The share of nanomedicine to the total global pharmaceutical market is estimated at 5.3 percent in 2011 indicating its niche character presently.

In Japan, for various reasons, the nanomedicine market size in terms of the total market is much smaller. A rough estimate shows that the share is between 1 to 2 percent corresponding to approximately US$1 to 2 billion. A limited number of approved Japanese nanodrugs together with a long time until approved foreign products entered the Japanese market have seemingly slowed the market expansion.

Japan = World's 2nd largest pharmaceutical market!

  • Japan is the 2nd largest pharmaceutical market in the world, marking JPY 10 trillion (USD 84.4 billion) in ethical drug in 2016.
  • Nikkei Stock Average has been continuously increasing since mid October, 2016.
  • The government is to ease the regulations to develop new medicines for intractable diseases by shortening 5 years of drug development time.
  • Japan hugely depends on imported pharmaceutical products. The annual import value in Japan was JPY 1.94 trillion (USD 16 billion) in 2015 compared to the export value of JPY 0.32 trillion (USD 2.7 billion).

  • Unit: USD Billion
    Source: Japan Pharmaceutical Manufacturers Association “Data Book 2016”

Japan’s pharmaceutical industry is the world’s second largest market, after U.S., valued at US$112.1 billion in 2012 or 11.6 percent of the world market. Historically, the market has been protected from foreign competition. These days, however, deregulation has prompted investment from abroad and increased the presence of foreign companies. The pharmaceutical industry is one of the few industrial sectors in which Japan has a trade deficit. Japan imports more than two times what it exports. The rapid aging of the population and the weak global competitiveness of domestic companies are contributing factors to the trade deficit.

Japan Nanomedicine Market Size:

There is no market information available on the size of Japan’s nanomedicine market published by any of the large Japanese market research companies. Table 2 below tries to estimate the market size. The global nanomedicine market was estimated to be about 5 percent of the global pharmaceutical market in 2010 and 2011. In case of Japan, this ratio is much lower compared to the global nanomedicine market. A rough estimate indicates that the market size was approximately 1-2 percent of the Japanese pharmaceutical market in 2011-2012, or roughly between US$1 billion – US$2 billion. The drug lag of imported nanopharmaceuticals (explained in section 3.5.) is one cause of this. Nanomedicines have not been defined in Japan and are regulated within the general framework of the Pharmaceutical Affairs Law (PAL) on a product-by-product basis (20).

Approved Nanopharmaceutical Products by Application:

As there is no specific definition for drug and device (nanocarrier) combinations, they are regulated as drugs or medical devices according to their main function or purpose (20).

Pharmaceuticals are classified as nanomedicine by their sizes, i.e. materials in the submicron range.Information on marketed nanopharmaceuticals in Japan comes from various sources (21) including “Current Initiatives in Japan for Nanomedicines”, Kumiko Sakai-Kato, Toru Kawanishi, 2011, National Institute of Health Sciences (NIHS) and Ministry of Health, Labour and Welfare (MHLW) (22).

Trade name   

Technology

Compound

Company

Ropion

Lipid emulsion    

Flurbiprofen        

 Kaken (JPN)

Visudyne

Liposome

Verteporfin    

Novartis

Zevalin

Antibody Conjugates

Zevalin  

Bayer

Somavert

PEGylated protein     

Pegvisomant

Pfizer

Emend

Nanocrystal

Aprepitant  

Merck

Abraxane

Polymeric Nanoparticles

Paclitaxel

Abraxis

Government Pushing for Change:

order to reduce the time span from discovery and innovation to commercialization, the importance to establish open user facility networks to promote the integration of dissimilar fields and academic-industry collaboration is emphasized.

It is apparent that the government is aiming at more concrete and speedy results for R&D. Issue-driven innovation based on “exit-oriented” R&D is targeted to impact the competitive power of related industries.

A report by the Japan Science & Technology Agency titled “Japan’s New Science and Innovation Policy – Beyond the Boundaries for Innovation”, published in 2016 (50) lists up the time span for selected target applications of nanomedicine, such as:

  • Molecular imaging (2015-2020)
  • Integrated system of drug delivery, diagnosis and treatment (2015-2020)
  • Implant devices for diagnosis and treatment (2020-2030)
  • Nano-cell surgery (2020-2030)
  • 3D-imaging in cells (2020-2030)

These are quite ambitious targets showing the directions where R&D will be focused.

In addition to the latest basic plan, there are other signals that the government is increasingly prioritizing innovative medicine. For instance, The Ministry of Health, Labour and Welfare will jointly with the European Union (EU) promote the development of nano-based block copolymer micelles. Together with European Medicines Agency (EMA) the ministry has released a reflection paper (February 2013) emphasizing that such micelles are able to preferentially accumulate in solid tumors (51).

Nanomedicine – Research and Development in Japan:

  • University of Tokyo
  • Hokkaido University
  • Osaka Prefecture University
  • Osaka University
  • Tohoku University
  • National Institute for Materials Science

The Japanese Nanomedicine Industry:

Nanomedicine start-ups and small-medium enterprises have driven the innovation process, not only in US and Europe but also in Japan. The commercialization of nanopharmaceuticals have basically followed three types of business models (67), such as:

  • Development of a nanotechnology platform used to add value to second-party products
  • Development and manufacturing of high-value materials for the pharmaceutical industry
  • Development of nanotechnology-improved pharmaceuticals or medical devices

The majority of start-ups has adopted the third business model utilizing nanotechnology to develop own proprietary product pipelines. Often such companies introduce new or standard drugs that are delivered with a drug delivery system. Then they try to team up with pharmaceutical companies that take the products through the clinical trials.

  • NanoCarrier Co., Ltd.
  • LTT Bio-Pharma Co., Ltd.
  • Mebiopharm Co., Ltd.
  • Nippon Kayaku Co., Ltd
  • Kowa Company Ltd.
  • Mitsubishi Tanabe Pharma Corporation
  • Taisho Pharmaceutical Co., Ltd.
  • Astellas Pharma Inc
  • Kaken Pharmaceutical Co., Ltd.

Pharmaceutical Regulations in Japan:

Manufacturing, importation, and sales of drugs and medical devices are regulated by the Pharmaceutical Affairs Law (PAL) of Japan.

All manufacturing and marketing applications in Japan for drugs and devices are reviewed by the Pharmaceutical and Medical Devices Agency (PMDA) (83). All applications are thoroughly reviewed before PMDA submits an approval recommendation to the Ministry of Health, Labour and Welfare (MHLW).

Under PAL, when importing to Japan and selling pharmaceutical products manufactured in other countries, a license for marketing authorization is required. The Marketing Authorization Holder (MAH) will be the owner of the license for marketing authorization.

The MAH must be based in Japan and can be the foreign company’s Japan office, the foreign company’s distributor, or an independent third party acting as the Designated Marketing Authorization Holder (DMAH).

To import and market a new drug in Japan, an approval (marketing approval) will be necessary. And the approval must be held by the Marketing Authorization Holder.

A foreign manufacturer intending to manufacture drugs in foreign countries and export them to Japan, is required to be accredited by MHLW as an “Accredited Foreign Manufacturer” (84). And it is necessary to obtain accreditation for each foreign factory location at which pharmaceuticals for export are manufactured.

The appointed MAH will be responsible for the labelling and advertising of the pharmaceuticals in Japan. As stipulated in PAL, the manufacturer’s/seller’s address, name of product, production indication, name of ingredients, expiration, etc., must be printed on the container of drugs.

Overall research in various disciplines:

 

The North American nanomedicine market held the majority of global market share in 2012 because of the rapidly growing nanomedicine market in the Asia-Pacific, Latin American and African region, presence of large number of patented nanomedicine products and favorable regulatory framework in the region. In addition, the presence of sophisticated healthcare infrastructure supports development of advanced products such as nano probes, nanorobots, monoclonal antibody based immunoassays and nanoparticle based imaging agents for early detection of diseases.

However, the Asia-Pacific region is expected to grow at a faster CAGR owing to presence of high unmet healthcare needs, research collaborations and increase in nanomedicine research funding in emerging economies such as China, India and other economies in the region. China is expected to surpass the United States in terms of nanotechnology funding in the near future, which indicates the growth offered by this region.

Major Nano Delivery Associations around the Globe:

  • American Nano Society
  • European Biotechnology Thematic Network Association
  • Society for Biomaterials
  • Nano Canadian Society
  • American Academy of NanoMedicine
  • American Association for the Advancement of Science
  • Nanometer-Scale Science and Technology Division of the American Vaccum Society
  • NanoScience and Technology Institute
  • ASME NanoTechnology Institute
  • Foresight Nanotech Institute
  • International Association of NanoTechnology
  • The Institute of NanoTechnology
  • Microscopy Society of America
  • Nano Business Alliance
  • European NanoTechnology Gateway
  • Scottish Center for NanoTechnology in Construction Materials
  • Royal Society-NanoTechnology and NanoScience
  • Czech NanoTechnology Industries Association
  • Erwin Schrodinger Society for NanoSciences
  • Innovationsallianz Carbon NanoTubes
  • NanoTechnologies for Tommorow's Society
  • American Association for the Advancement of Science

Companies involved in Nano Delivery:

USA

  • Oncolytics Biotech
  • Bristol-Myers Squibb
  • GlaxoSmithKline
  • Bend Research
  • Pfizer
  • BioDelivery Sciences
  • GE Healthcare
  • Mallinckrodt plc
  • Nanosphere Inc., USA
  • Pfizer Inc., USA
  • Merck & Co Inc., USA
  • Celgene Corporation, USA
  • CombiMatrix Corporation, USA
  • Abbott Laboratories
  • Many Major companies in the Nano Delivery market.

Global

  • PolyActivaUnilife
  • Mati Therapeutics
  • Formac Pharmaceuticals
  • Battelle
  • Toxikon
  • Novartis

 

 

Past Conference Report

NanoDelivery 2017

Nanodelivery 2017 Report

Held in Osaka, Japan, the International Conference and Exhibition on Nanomedicine and Drug Delivery was an unprecedented event, Organized by Conference Series LLC and supported by Controlled Release society, European society for biomaterials, Nanotechnology World Association and Australian Nanotechnology Networks.

Nanodelivery 2017 was held during May 29-31, 2017 at Hotel Hyatt Regency Osaka; Japan with the theme “Challenges and Innovations in Nanomedicine and Drug Delivery Research” drew benevolent response and agile  participation from the Academicians, Scientists, Professors, Chairman’s, CEOs, Presidents, Directors, students, around the globe in the fields of Nanomedicine and Drug Delivery systems, who made this event successful. It also provided invaluable networking opportunity, deploying the foundation for new research endeavors and development projects.

The meeting was carried out through varied sessions, in which the discussions were held on the following major scientific tracks:

  • Nanomedicine
  • Design of Nanodrugs
  • Personalized Nanomedicine
  • Nanomaterials for drug delivery
  • Nanomedicine and Nanotechnology
  • Synthesis of Nanoparticles for Drug Delivery
  • Drug Delivery Research
  • Novel Drug Delivery Systems
  • Smart Drug Delivery Technology
  • Regenerative Medicine and Tissue Engineering
  • Nano Pharmaceuticals
  • Nano Pharmaceutical Industry and Market and Many More……

The conference was initiated with a series of lectures delivered by the Honorable Guests, including

Conference Series LLC offers its heartfelt appreciation to organizations such as European society for biomaterials, Nanotechnology World Association , Controlled Release society, Nanotechnology Industries Association (NIA), Australian Nanotechnology Networks, American Nano Society and obliged to the Organizing Committee Members, adepts of field, company representatives, various outside experts and other eminent personalities who supported the conference by accelerating the discussion forums.

We Thanks to our media Partners for they support for the conference such as Asia Research News,  European pharmaceutical review,  Nanonextnl, Nanonetpl, SciDoc Publishers, PharmaVOICE and Elsevier

With the grand success of Nanodelivery 2017, Conference Series LLC is proud to announce the "2nd International Conference and Exhibition on Nanomedicine and Drug Delivery " to be held during May 14-16, 2018 at Tokyo, Japan.

For More details visit: http://nanomedicine.pharmaceuticalconferences.com/

Let us meet Again @ Nanodelivery 2018


Past Reports  Gallery